Metoclopramide
- TRADE NAMES: Apo-Metoclop; Duraclamid; Emex; Gastrocil; Gastronerton; Maxeran; Maxolon; Mygdalon; Primperan; Reglan (Wyeth)
- INDICATIONS: Gastroesophageal reflux
- CLASS: Antiemetic, Dopamine receptor antagonist
- HALF-LIFE: 4–6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acetaminophen, Amitriptyline, Atovaquone, Atovaquone/Proguanil, Bromocriptine, Citalopram, Darifenacin, Hydromorphone, Levodopa, Levodopa, Levomepromazine, Lurasidone, Mepenzolate, Meptazinol, Naratriptan, Olanzapine, Oxybutynin, Paliperidone, Posaconazole, Propyphenazone, Risperidone, Rotigotine, Safinamide, Sertraline, Tetrabenazine, Tiotropium, Trospium, Venlafaxine, Ziprasidone, Zuclopenthixol
PREGNANCY CATEGORY: B
TARDIVE DYSKINESIA
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 08/13/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
